

May 8 – World Ovarian Cancer Day, was established in 2013 by a group of leaders from ovarian cancer advocacy organizations around the world
By the end of April 2022, we calculated a total number of publications and SDA reports released by the HTA bodies and dedicated to the ovarian cancer.
This number is being updated daily and we continue to monitor publication activity moving forward and plan to provide updates at the future. If you are interested to see which are the approved/rejected drugs, your next stop is the HTA Accelerator.
If you want to have a demo or to request a strategic analysis by our consultants, please visit here or contact hta-accelerator@iqvia.com
For more, please visit HTA Accelerator page.